These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 14243392)

  • 21. Fibrinogen and its derivatives in intravascular coagulation. A review.
    Gerrits WB
    Neth J Med; 1975; 18(1):31-44. PubMed ID: 124019
    [No Abstract]   [Full Text] [Related]  

  • 22. STUDIES ON THE PHYSIOLOGICAL ACTIVITY OF THE PEPTIDE RELEASED DURING THE FIBRINOGEN-FIBRIN CONVERSION.
    OSBAHR AJ; GLADNER JA; LAKI K
    Biochim Biophys Acta; 1964 Jun; 86():535-42. PubMed ID: 14192905
    [No Abstract]   [Full Text] [Related]  

  • 23. [METHOD OFSTUDY OF BLOOD COAGULATION BASED ON THE CHANGES IN ELECTRIC RESISTANCE OF THE FIBRINNETWORK].
    BAYOBAYO JM; ZULUAGAJARAMILLO E
    Arch Inst Farmacol Exp (Madr); 1963; 15():75-93. PubMed ID: 14049389
    [No Abstract]   [Full Text] [Related]  

  • 24. [NEUTRALIZATION OF ANTIPLASMIN IN THE BLOOD DURING PROTECTIVE REACTIONS OF THE PHYSIOLOGIC ANTICOAGULATION SYSTEM].
    KUDRIASHOV BA; ANDREENKO GV; KALISHEVSKAIA TM
    Probl Gematol Pereliv Krovi; 1964 Apr; 9():12-5. PubMed ID: 14195816
    [No Abstract]   [Full Text] [Related]  

  • 25. [BLOOD COAGULATION IN HYPERTENSION].
    URANIUK KG
    Klin Med (Mosk); 1963 Aug; 41():38-42. PubMed ID: 14086885
    [No Abstract]   [Full Text] [Related]  

  • 26. A novel natural mutation AαPhe98Ile in the fibrinogen coiled-coil affects fibrinogen function.
    Riedelová-Reicheltová Z; Kotlín R; Suttnar J; Geierová V; Riedel T; Májek P; Dyr JE
    Thromb Haemost; 2014 Jan; 111(1):79-87. PubMed ID: 24108601
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Modern data on the chemistry and physiology of fibrinogen].
    Andreenko GV
    Usp Sovrem Biol; 1974; 77(1):51-69. PubMed ID: 4282801
    [No Abstract]   [Full Text] [Related]  

  • 28. Thrombin generation and fibrin clot structure.
    Wolberg AS
    Blood Rev; 2007 May; 21(3):131-42. PubMed ID: 17208341
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pathophysiology and clinical aspects of fibrinolysis and inhibition of coagulation. Experimental and clinical studies with special reference to women on oral contraceptives and selected groups of thrombosis prone patients.
    Jespersen J
    Dan Med Bull; 1988 Feb; 35(1):1-33. PubMed ID: 3277796
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [EFFECT OF VITAMIN B12 ON THE FUNCTION OF THE PHYSIOLOGICAL ANTI-COAGULATION SYSTEM OF THE ORGANISM].
    KUDRIASHOV BA; ANDREENKO GV; SYTINA NP; IVANOVA EA; PLIUSHCH LI
    Vopr Med Khim; 1964; 10():269-73. PubMed ID: 14221551
    [No Abstract]   [Full Text] [Related]  

  • 31. The haemostatic balance in groups of thrombosis-prone patients. With particular reference to fibrinolysis in patients with myocardial infarction.
    Gram J
    Dan Med Bull; 1990 Jun; 37(3):210-34. PubMed ID: 2192835
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The aggregation of fibrin powder suspensions by fibrinogen and its measurement by a sedimentation parameter.
    Exner T; Richard KA; Kronenberg H
    Thromb Res; 1975 Aug; 7(2):315-22. PubMed ID: 1162650
    [No Abstract]   [Full Text] [Related]  

  • 33. [Role of heparin in the process of blood coagulation and fibrinolysis].
    Liapina LA
    Usp Sovrem Biol; 1977; 84(3):338-52. PubMed ID: 343416
    [No Abstract]   [Full Text] [Related]  

  • 34. Mechanism of accelerated lysis of blood clots from heparinised blood.
    Morris CJ; Williamson N; Wolf P
    Haemostasis; 1981; 10(5):245-60. PubMed ID: 7274777
    [No Abstract]   [Full Text] [Related]  

  • 35. [Analysis of lytic effect on fibrin of immobilized heparin in complex with plasma proteins].
    Platé NA; Valuev LI; Gumirova FKh; Maklakova IA
    Vopr Med Khim; 1982; 28(5):19-23. PubMed ID: 6217639
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [THE EFFECT OF DISTURBANCES OF VASCULAR-CONNECTIVE TISSUE PERMEABILITY DUE TO HISTAMINE ON SOME PHYSIOLOGICAL INDICES OF THE BLOOD ANTICOAGULANT SYSTEM UNDER EXPERIMENTAL CONDITIONS].
    POSTNOV IuV; ANANCHENKO VG; ULITINA PD
    Arkh Patol; 1964; 26():31-8. PubMed ID: 14222172
    [No Abstract]   [Full Text] [Related]  

  • 37. [THROMBIN-MEDIATED EFFECTS OF BLOOD MICROPARTICLES ON FORMATION, STRUCTURE, AND STABILITY OF FIBRIN CLOTS].
    Nabiullina RM; Mustafin IG; Ataullakhanov FI; Litvinov RI; Zubairova LD
    Ross Fiziol Zh Im I M Sechenova; 2015 Jul; 101(7):812-21. PubMed ID: 26591054
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Equilibria in the fibrinogen--fibrin conversion. 8. Polymerization of acceptor-modified fibrin monomer.
    Endres GF; Scheraga HA
    Biochemistry; 1968 Dec; 7(12):4219-26. PubMed ID: 5750166
    [No Abstract]   [Full Text] [Related]  

  • 39. Assays of fibrin network properties altered by VKAs in atrial fibrillation - importance of using an appropriate coagulation trigger.
    Ząbczyk M; Blombäck M; Majewski J; Karkowski G; Wallen HN; Undas A; He S
    Thromb Haemost; 2015 Apr; 113(4):851-61. PubMed ID: 25518887
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Heparin].
    Roszkowska W; Worowski K
    Postepy Hig Med Dosw; 1984; 38(1):73-124. PubMed ID: 6387687
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.